Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
phagos logo — Unleash Bacteriophage Potential

phagos

Unleash Bacteriophage Potential

Founded 2021 France France 27 employees Grant Total: $4.49M Biotechnology

General Information

Company Name phagos
Founded Year 2021
Location France France +2
Employees 27
Industries Biotechnology
Funding Stage Grant
Social

Get notified when phagos moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About phagos

Phagos Biotech is a biotechnology startup founded in 2021 with the mission to address the urgent global challenge of antibiotic resistance. Their slogan "Unleash Bacteriophage Potential" reflects their dedication to harnessing the natural predator of bacteria, the bacteriophage, as a solution for life-threatening infectious diseases. Recognizing antibiotic resistance as a top 10 threat to humanity, Phagos is committed to leveraging entrepreneurship for positive change in the field of healthcare. Their approach is not only innovative but also sustainable, aiming to provide an alternative to antibiotics with the potential to revolutionize the industry. The recent €1.35M grant investment received by Phagos on 18 August 2023 from Bpifrance indicates a strong endorsement of their groundbreaking work. With the headquarter in France, Phagos Biotech is positioned at the forefront of the biotechnology industry, offering investors an opportunity to support a disruptive solution to a pressing global health concern. As they invite others to embark on the journey to Unleash Bacteriophage Potential, Phagos Biotech presents a compelling vision for the future of healthcare and biotechnology.

Taxonomy: Antibiotic resistance, Bacteriophage therapy, Infectious diseases, Healthcare innovation, Public health, Medical research, Global health crisis, Entrepreneurship for social good

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
18 Aug 2023
Seed Round •••••• 7
Investor Investor Investor Investor Investor Investor
•••• •••• 		28 Sep 2022
Grant •••••• 2
Investor
•••• •••• 		05 Jul 2022
Non Equity Assistance •••••• - 05 Nov 2021
Pre Seed Round •••••• - 11 Sep 2021

phagos Alternatives & Competitors

phagos vs
Phyla
Phyla United States

Making benzoyl peroxide obsolete for acne.

Series A
26 employees
Biotechnology, Health Care
Compare phagos vs Phyla
phagos vs
Cytophage Technologies Ltd.
Cytophage Technologies Ltd. Canada

Award-winning biotechnology company specializing in bacteriophage therapy development, based in Winn...

18 employees
Education, Health Care
Compare phagos vs Cytophage Technologies Ltd.
phagos vs
PhagePro
PhagePro United States

Phages for a healthier world.

Grant
7 employees
Biotechnology
Compare phagos vs PhagePro

FAQ About phagos

Unleash Bacteriophage Potential
phagos was founded in 2021.
phagos is headquartered in France.
phagos operates in the following industries: Biotechnology.
phagos has approximately 27 employees.
phagos has completed 5 funding rounds, raising a total of $4.49M. The latest funding stage is Grant.
Top alternatives and competitors to phagos include Phyla, Cytophage Technologies Ltd., PhagePro, Biopesticide Ltd., Armata Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
phagos and Phyla are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors phagos and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy